(Q40811613)

English

Nigral degeneration in Parkinson's disease

scientific article published on January 1993

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23 September 2017

1 reference

Europe PubMed Central

title

Nigral degeneration in Parkinson's disease (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23 September 2017

1 reference

Rinne JO

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8302305

retrieved

23 September 2017

language of work or name

English

0 references

publication date

1 January 1993

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

8302305

retrieved

23 September 2017

volume

8 Suppl 1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8302305

retrieved

23 September 2017

page(s)

S31-5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8302305

retrieved

23 September 2017

cites work

Acid monoamine metabolites in the cerebrospinal fluid of patients with Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FMDS.870080507

retrieved

21 January 2018

Selegiline (deprenyl) treatment and death of nigral neurons in Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FMDS.870080507

retrieved

21 January 2018

Personality (MMPI) and cognitive (WAIS) changes after levodopa treatment

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FMDS.870080507

retrieved

21 January 2018

Selegiline as initial treatment in de novo parkinsonian patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FMDS.870080507

retrieved

21 January 2018

Selegiline use to prevent progression of Parkinson's disease. Experience in 22 de novo patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FMDS.870080507

retrieved

21 January 2018

Identifiers

DOI

10.1002/MDS.870080507

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8302305

retrieved

23 September 2017

PubMed publication ID

8302305

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8302305

retrieved

23 September 2017

(Q40811613)

Nigral degeneration in Parkinson's disease

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)